% | $
Quotes you view appear here for quick access.

Prima Biomed Ltd. Message Board

  • trendsettr66 trendsettr66 Oct 18, 2012 11:52 PM Flag

    Unique focus

    Prima BioMed’s leading drug, CVac™ targets cancer cells expressing mucin-1 which are prolific on the surface of many cancers. Mucin-1 protein is not only common in ovarian cancer; it is also expressed in prostate, kidney, pancreatic, breast, colon, and lung cancer cells. This significantly opens the market for CVac™ to be applied to a variety of cancer types which is unique compared to other drug discovery and development companies.

0.970.00(0.00%)Jul 1 4:00 PMEDT